ストックスクリーナーアプリを入手
129.38
0.35%
-0.46
アフターアワーズ：
129.80
0.42
+0.32%
Abbott Laboratories (ABT) 最新ニュース
Global Neuroprosthetics Market Expanding Rapidly at a CAGR of ~13% by 2032 Amid Surge in Demand for Advanced Neurological Treatments | DelveInsight - GlobeNewswire Inc.
Medtronic seeks FDA nod for insulin pump (MDT:NYSE) - Seeking Alpha
EPD Growth in Emerging Market Supports Abbott Stock Amid Macro Woes - TradingView
June 6th Options Now Available For Abbott Laboratories (ABT) - Nasdaq
The Zacks Analyst Blog Highlights Coca-Cola, Abbott Laboratories, RTX, Investors Title and Armanino Foods of Distinction - Yahoo Finance
Top Analyst Reports for Coca-Cola, Abbott & RTX - Yahoo Finance
Abbott expects a ‘few hundred million’ in tariff costs in 2025 - Supply Chain Dive
Bullish on Abbott Laboratories - The Globe and Mail
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know - Yahoo Finance
Illinois quick hits: State representative under investigation; Abbott plans expansion - www.cities929.com
Drug Delivery Device Market Future Business Opportunities - openPR.com
Leukemia Screening Market Overall Study Report 2025-2032 | - openPR.com
Abbott Laboratories (ABT)'s Winning Formula: Financial Metrics a - GuruFocus
Insiders At Abbott Laboratories Sold US$3.3m In Stock, Alluding To Potential Weakness - Yahoo Finance
Lobbying Update: $50,000 of ABBOTT LABORATORIES lobbying was just disclosed - Nasdaq
Jim Cramer Applauds Abbott Laboratories (ABT): “A Tour de Force Quarter – Robert Ford Is Keeping the Miles White Legacy Alive” - Insider Monkey
Abbott Laboratories Invests $500M in U.S. Amidst Trade Uncertainties, Creating 300 New Jobs in Illinois and Dallas - Hoodline
Abbott Labs' Rally Is Well DeservedFade The Rally For Now - Seeking Alpha
Abbott Laboratories to invest $500M in manufacturing, add 200 jobs in Illinois - Chicago Sun-Times
Abbott Laboratories (NYSE:ABT) Q1 2025 Earnings Call Transcript - MSN
Abbott's Q1 earnings in focus as analysts see path to beat amid business strength - MSN
Brazil Enteral Nutrition Market Overall Study Report 2025-2032 - openPR.com
Tariff-Resistant Abbott Laboratories on Track for New Highs - Investing.com
Abbott Laboratories’ Earnings Call Highlights Robust Growth - TipRanks
Abbott Laboratories Plans $500M Manufacturing, R&D Expansion In DFW and Chicago - Bisnow
Abbott Laboratories Adjusts Financial Outlook With Increased Price Target - Evrim Ağacı
Abbott Laboratories First Quarter 2025 Earnings: EPS Misses Expectations - simplywall.st
RBC Capital lifts Abbott Labs target to $145, maintains Outperform By Investing.com - Investing.com India
Abbott Labs stock target raised to $144 by Bernstein SocGen - Investing.com India
RBC Capital lifts Abbott Labs target to $145, maintains Outperform - Investing.com
UBS maintains Buy on Abbott Labs with $148 price target By Investing.com - Investing.com India
Abbott price target raised to $140 from $138 at Evercore ISI - Yahoo Finance
Abbott Labs (ABT) Stock: Earnings Beat with Strong MedTech Growth and $500M U.S. Investment - CoinCentral
UBS maintains Buy on Abbott Labs with $148 price target - Investing.com
These Analysts Boost Their Forecasts On Abbott Laboratories After Better-Than-Expected Earnings - Benzinga
Piper Sandler raises Abbott Labs target to $145, keeps Overweight By Investing.com - Investing.com India
Piper Sandler raises Abbott Labs target to $145, keeps Overweight - Investing.com
Citi Reaffirms Their Buy Rating on Abbott Laboratories (ABT) - The Globe and Mail
Demystifying Abbott Laboratories: Insights From 11 Analyst Reviews - Benzinga
RBC Capital Increases Price Target for Abbott (ABT) to $145 | ABT Stock News - GuruFocus
Stifel cuts Abbott Labs stock target to $135, maintains buy rating - Investing.com India
Abbott Laboratories: Strong Performance and Resilience Justify Buy Rating Amid Economic Challenges - TipRanks
Oppenheimer Increases Price Target for Abbott (ABT) to $140 | ABT Stock News - GuruFocus
Abbott Laboratories (ABT): Among the Innovative Healthcare Stocks to Watch in 2025 - Yahoo Finance
Bernstein Boosts Abbott (ABT) Price Target to $144 on Strong Performance | ABT Stock News - GuruFocus
BTIG Ups Abbott (ABT) Price Target After Impressive Q1 Earnings | ABT Stock News - GuruFocus
Abbott Laboratories: Strong Growth and Resilience Justify Buy Rating - TipRanks
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT) and Blueprint Medicines (BPMC) - The Globe and Mail
Oppenheimer lifts Abbott Labs target to $140, maintains outperform By Investing.com - Investing.com India
Oppenheimer lifts Abbott Labs target to $140, maintains outperform - Investing.com
BTIG raises Abbott Labs stock price target to $145 - Investing.com
Raymond James raises Abbott Labs price target to $142 - Investing.com
Raymond James raises Abbott Labs price target to $142 By Investing.com - Investing.com UK
Street View: Abbott's effective management could help it triumph over tariffs - TradingView
Abbott Laboratories (ABT) Q1 2025 Earnings Call Highlights: Strong Growth in Medical Devices ... - Yahoo Finance
Abbott Laboratories (ABT) Q1 2025 Earnings Call Highlights: Strong Growth in Medical Devices and Nutrition Amidst Diagnostics Challenges - GuruFocus
Abbott Laboratories Reports Strong Q1 2025 Results - TipRanks
Abbott to Expand US Manufacturing as Tariffs Loom - MSN
Abbott Labs Forecasts Tariff Impact of a ‘Few Hundred Million Dollars’ - WSJ
2.24%
大文字化:
|
ボリューム (24 時間):